RACT

RACT is a topical ophthalmic combination drug developed and marketed by Jainson Biotech (India) Pvt. Ltd. It is formulated as eye drops containing potassium iodide (3.3% w/v), calcium chloride (1% w/v), and sodium chloride (0.83% w/v). The product is primarily indicated for the prevention and delay of cataractogenesis (the formation of cataracts) and the treatment of other degenerative eye conditions. While the specific molecular mechanism of action is not extensively documented in clinical literature, the formulation is intended to support ocular health and potentially improve eyesight through the combined metabolic effects of its mineral salt components. It is an approved pharmaceutical product available in the Indian market and contains phenylmercuric nitrate as a preservative.

Brand names

RACT